SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.

Saved in:
Bibliographic Details
Title: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.
Authors: Zhang, Jing1 (AUTHOR) jzhangcqmu@hospital.cqmu.edu.cn, Liu, Xiao-han1 (AUTHOR), Li, Cong1 (AUTHOR), Wu, Xiao-xing2 (AUTHOR), Chen, Yan-lin3 (AUTHOR), Li, Wen-wen4 (AUTHOR), Li, Xian4 (AUTHOR), Gong, Fan1 (AUTHOR), Tang, Qin1 (AUTHOR), Jiang, Dan1 (AUTHOR)
Source: Journal of Experimental & Clinical Cancer Research (17569966). 5/7/2020, Vol. 39 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17569966
DOI:10.1186/s13046-020-01589-9